Rhythm Versus Rate Control in the Contemporary Management of Atrial Fibrillation In-Hospital††The views expressed in this report are those of the investigators and do not necessarily represent the views of the FDA.

American Journal of Cardiology

Volumn 101, Issue 8, 2008, Pages 1134-1141

  Allen LaPointe, Nancy M ^a   Sun, Jie Lena ^a   Kaplan, Sigal ^b   d'Almada, Phil ^a   Al Khatib, Sana M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; FLECAINIDE; HEPARIN; IBUTILIDE; LOW MOLECULAR WEIGHT HEPARIN; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

ADULT; AGE; AGED; ARTICLE; CARDIOVERSION; CATHETER ABLATION; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HOSPITAL PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; DIGOXIN; DRUG UTILIZATION; ELECTRIC COUNTERSHOCK; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPECIALTIES, MEDICAL; UNITED STATES; WARFARIN; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 41449100260     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.067     Document Type: Article

References (26)

1. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H.J., Frye R.L., Halperin J.L., Kay G.N., Klein W.W., Lévy S., et al., American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38 (2001) 1231-1266
2. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., et al., American College of Cardiology, American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48 (2006) 854-906
3. Hohnloser S.H., Kuck K.H., and Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 356 (2000) 1789-1794
4. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., Said S.A., Darmanata J.I., Timmermans A.J., Tijssen J.G., and Crijns H.J. Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
5. Carlsson J., Miketic S., Windeler J., Cuneo A., Haun S., Micus S., Walter S., Tebbe U., and STAF Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 41 (2003) 1690-1696
6. Opolski G., Torbicki A., Kosior D.A., Szulc M., Wozakowska-Kaplon B., Kolodziej P., Achremczyk P., and Investigators of the Polish How to Treat Chronic Atrial Fibrillation Study. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) study. Chest 126 (2004) 476-486
7. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalquist J.E., Corley S.D., and Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
8. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
9. Glazer N.L., Dublin S., Smith N.L., French B., Jackson L.A., Hrachovec J.B., Siscovick D.S., Psaty B.M., and Heckbert S.R. Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med 167 (2007) 246-252
10. Liang K., and Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
11. McNamara R.L., Brass L.M., Drozda Jr. J.P., Go A.S., Halperin J.L., Kerr C.R., Lévy S., Malenka D.J., Mittal S., Pelosi Jr. F., et al., American College of Cardiology, American Heart Association. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). J Am Coll Cardiol 44 (2004) 475-495
12. Chung M.K., Shemanski L., Sherman D.G., Greene H.L., Hogan D.B., Kellen J.C., Kim S.G., Martin L.W., Rosenberg Y., Wyse D.G., and AFFIRM Investigators. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) functional status substudy. J Am Coll Cardiol 46 (2005) 1891-1899
13. Singh S.N., Tang X.C., Singh B.N., Dorian P., Reda D.J., Harris C.L., Fletcher R.D., Sharma S.C., Atwood J.E., Jacobson A.K., et al., SAFE-T Investigators. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 48 (2006) 721-730
14. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., and Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32 (1998) 695-703
15. Middlekauff H.R., Stevenson W.G., and Stevenson L.W. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84 (1991) 40-48
16. Crijns H.J., Tjeerdsma G., de Kam P.J., Boomsma F., van Gelder I.C., van den Berg M.P., and van Veldhuisen D.J. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21 (2000) 1238-1245
17. Verma A., and Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients?. Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation 112 (2005) 1214-1222
18. Pappone C., Augello G., Sala S., Gugliotta F., Vicedomini G., Gulletta S., Paglino G., Mazzone P., Sora N., Greiss I., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J Am Coll Cardiol 48 (2006) 2340-2347
19. Oral H., Pappone C., Chugh A., Good E., Bogun F., Pelosi Jr. F., Bates E.R., Lehmann M.H., Vicedomini G., Augello G., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 354 (2006) 934-941
20. Stabile G., Bertaglia E., Senatore G., De Simone A., Zoppo F., Donnici G., Turco P., Pascotto P., Fazzari M., and Vitale D.F. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study). Eur Heart J 27 (2006) 216-221
21. de Denus S., Sanoski C.A., Carlsson J., Opolski G., and Spinler S.A. Rate vs. rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 165 (2005) 258-262
22. Zimetbaum P., and Josephson M.E. Is there a role for maintaining sinus rhythm in patients with atrial fibrillation?. Ann Intern Med 141 (2004) 720-726
23. Sherman D.G., Kim S.G., Boop B.S., Corley S.D., Dimarco J.P., Hart R.G., Haywood L.J., Hoyte K., Kaufman E.S., Kim M.H., et al., National Heart, Lung, and Blood Institute AFFIRM Investigators. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-Up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med 165 (2005) 1185-1191
24. Reynolds M.R., Lavelle T., Essebag V., Cohen D.J., and Zimetbaum P. Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse Events and Lifestyle (FRACTAL) study. Am Heart J 152 (2006) 1097-1103
25. Choudhry N.K., Soumerai S.B., Normand S.L., Ross-Degnan D., Laupacis A., and Anderson G.M. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med 119 (2006) 607-615
26. Waldo A.L., Becker R.C., Tapson V.F., Colgan K.J., and NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 46 (2005) 1729-1736